Our results reported here may indicate a novel therapeutic strategy against K-Ras-dependent malignancies, as targeting either p38γ or Hsp90 decreases MT, but not WT, K-Ras expression and effectively inhibit K-Ras MT colon cancer growth (Figure 1-6). The gene discussed is HSP90AA1; the disease is malignant colon neoplasm.